GBSN is a POS. No one's buying it, in the healthcare industry that is. The big reason why is: Why would CEO Ashton give up his cash cow? The R/Ss helps him maintain the lifestyle to which he is accustomed. As before, GBSN's "wash, rinse, repeat" cycle of R/S and dilution will continue.
Nothing I say, post, or do should ever be considered financial advice. It is just my personal opinion. I may be holding a long, short or no position. I am NOT or NEVER have been compensated to post on here and my posts are for entertainment purposes only.